Oscar Health, Inc. $OSCR Stock Position Increased by Virtu Financial LLC

Virtu Financial LLC raised its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 99.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 127,647 shares of the company’s stock after purchasing an additional 63,623 shares during the period. Virtu Financial LLC’s holdings in Oscar Health were worth $1,834,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the company. Jones Financial Companies Lllp boosted its position in Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after acquiring an additional 2,242 shares during the period. Strs Ohio bought a new position in Oscar Health during the 1st quarter valued at $30,000. Fifth Third Bancorp boosted its stake in Oscar Health by 148.7% during the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after purchasing an additional 1,413 shares in the last quarter. Quarry LP increased its position in shares of Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after purchasing an additional 1,469 shares during the period. Finally, Binnacle Investments Inc acquired a new position in shares of Oscar Health during the 2nd quarter valued at $75,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Stock Down 0.1%

OSCR stock opened at $28.37 on Friday. The firm has a market cap of $8.55 billion, a PE ratio of -48.09, a PEG ratio of 1.99 and a beta of 2.37. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26. The company has a fifty day simple moving average of $21.61 and a 200 day simple moving average of $16.93. Oscar Health, Inc. has a 1 year low of $10.69 and a 1 year high of $29.81.

Oscar Health (NYSE:OSCR) last announced its earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The business had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.90 billion. During the same quarter in the previous year, the firm posted $0.92 earnings per share. Oscar Health’s revenue was up 52.6% compared to the same quarter last year. Sell-side analysts anticipate that Oscar Health, Inc. will post 0.47 EPS for the current fiscal year.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, insider Janet Liang sold 12,475 shares of the stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $273,701.50. Following the completion of the transaction, the insider directly owned 259,057 shares in the company, valued at $5,683,710.58. This represents a 4.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Richard Scott Blackley sold 100,000 shares of the business’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $23.16, for a total transaction of $2,316,000.00. Following the completion of the sale, the chief financial officer owned 1,216,660 shares in the company, valued at $28,177,845.60. This represents a 7.59% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 189,660 shares of company stock worth $4,283,140 over the last three months. 24.39% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several brokerages have recently weighed in on OSCR. Zacks Research lowered Oscar Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 5th. Wolfe Research assumed coverage on Oscar Health in a report on Tuesday, May 5th. They set a “peer perform” rating on the stock. UBS Group upped their price target on shares of Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Wells Fargo & Company set a $20.00 price objective on shares of Oscar Health and gave the company an “equal weight” rating in a research report on Thursday, June 4th. Finally, Robert W. Baird lifted their price objective on shares of Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Three equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $20.78.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.